Received May 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Autoimmune disorder; he had an aneurysm and died; This serious case was reported by a consumer via sales rep and described the occurrence of autoimmune disorder in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced autoimmune disorder (Verbatim: Autoimmune disorder) (serious criteria death, GSK medically significant and other: Serious as per reporter) and aneurysm (Verbatim: he had an aneurysm and died) (serious criteria death). The patient died in APR-2025. The reported cause of death was autoimmune disorder and aneurysm. It was unknown if the reporter considered the autoimmune disorder and aneurysm to be related to Shingrix. The company considered the autoimmune disorder and aneurysm to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 29-APR-2025 The reporter was a neighbor of the patient who died. Reporter reported that after taken Shingrix, patient developed an autoimmune disorder in which he was prescribed continued use of steroids. An unknown amount of time later he had an aneurysm and died. The reporter stated death was sometime in last week (from the date of reporting) he/she thought and believed due to an aneurysm.; Sender's Comments: Autoimmune disorder and Aneurysm are unlisted events which are considered unrelated to GSK vaccine Shingrix.; Reported Cause(s) of Death: Autoimmune disorder; Aneurysm